Jefferies Group’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
$376K Sell
38,000
-159,161
-81% -$1.57M ﹤0.01% 733
2022
Q2
$2.1M Buy
+197,161
New +$2.1M 0.02% 312